Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Glabrone
Cat. No.:
0225LY-0910
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Glabrone is a compound that demonstrates antiviral activity specifically against the influenza virus.
Synonym:
60008-02-8; Morusin hydroperoxide; Eurycarpin B; 7-hydroxy-3-(5-hydroxy-2,2-dimethylchromen-6-yl)chromen-4-one; 4H-1-Benzopyran-4-one, 7-hydroxy-3-(5-hydroxy-2,2-dimethyl-2H-1-benzopyran-6-yl)-; 5',7-Dihydroxy-2',2'-dimethyl-2'H,4H-[3,6'-bichromen]-4-one; 7,2'-dihydroxy-6'',6''-dimethylpyrano-(2'',3''-4',3')isoflavone
CAS No.:
60008-02-8
Compound CID:
5317652
Formula:
C20H16O5
Formula Weight:
336.34
Specification
Relative Density:
1.368 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Glabrone can be used in natural product research to explore its potential estrogenic activity and antioxidant properties.
Library Information
Target:
PPAR; Viral protein
Receptor:
PPAR; Viral protein
Pathways:
DNA damage/DNA repair; Metabolism; Microbiology/Virology
Plate Number:
AOCL-12
Plate Location:
f11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 148.66 mM
